千红制药席位动向引关注 多路资金现分歧

Group 1 - The core point of the news is that Qianhong Pharmaceutical has attracted significant attention from various institutional investors in recent trading days, indicating potential interest in the stock [1] - The top buyer, a special seat from the Shenzhen Stock Connect, invested 245.44 million yuan, with a historical three-day price increase probability of 45.10% for stocks it has previously engaged with [1] - Other notable buyers include Lianhe Securities and Kaiyuan Securities, with their respective historical three-day price increase probabilities being 47.06% and close to 50% [1] Group 2 - The selling side shows a clear differentiation, with the Shenzhen Stock Connect special seat leading at 168.62 million yuan, while Guotai Junan Securities follows closely at 166.53 million yuan, which has a three-day price increase probability of 40.25% [1] - Kaiyuan Securities and Lianhe Securities also appear on the selling list, indicating some short-term trading characteristics among certain funds [1] - An institutional special seat appeared as the fifth seller with an investment of 67.10 million yuan, having a historical three-day price increase probability of 43.02% [2]